Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) EBT Margin (2024 - 2025)

Connect Biopharma Holdings' EBT Margin history spans 2 years, with the latest figure at 107118.75% for Q3 2025.

  • For Q3 2025, EBT Margin fell 10606715.0% year-over-year to 107118.75%; the TTM value through Sep 2025 reached 6862.89%, changed N/A, while the annual FY2024 figure was 59.17%, N/A changed from the prior year.
  • EBT Margin for Q3 2025 was 107118.75% at Connect Biopharma Holdings, down from 1260.74% in the prior quarter.
  • Across five years, EBT Margin topped out at 1051.6% in Q3 2024 and bottomed at 107118.75% in Q3 2025.